Bahrain 2nd in the world to approve the Pfizer/BioNTech vaccine
Bahrain’s approval of the Pfizer/BioNTech Covid-19 vaccine makes the Kingdom the second country in the world to grant an Emergency Use Authorisation (EUA) for the vaccine.
The confirmation of approval by the National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain, followed thorough analysis and review undertaken by the Authority of all available data. It is Bahrain’s second approval of a Covid-19 vaccine EUA, following the Kingdom’s approval in November of the Sinopharm vaccine for use by frontline workers.
Bahrain’s comprehensive “Test, Trace and Treat” Covid-19 response strategy, with one of the highest testing rates per capita in the world, has proved effective in breaking the chains of infection, managing down case numbers and saving lives.
